NCT00841542View on ClinicalTrials.gov

Amlodipine 10 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Healthy
Interventions
DRUG

Amlodipine Besylate

10 mg Tablet

DRUG

Norvasc®

10 mg Tablet

Trial Locations (1)

Unknown

Biovail Contract Research, Toronto

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00841542 - Amlodipine 10 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter